Physiol Rev Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Rev. 80: 681-715, 2000;
0031-9333/00 $15.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (69)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geers, C.
Right arrow Articles by Gros, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geers, C.
Right arrow Articles by Gros, G.

Physiological Reviews, Vol. 80, No. 2, April 2000, pp. 681-715
Copyright ©2000 by the American Physiological Society

Carbon Dioxide Transport and Carbonic Anhydrase in Blood and Muscle

Cornelia Geers and Gerolf Gros

Zentrum Physiologie, Medizinische Hochschule, Hannover, Germany

I. INTRODUCTION
II. CARBON DIOXIDE TRANSPORT IN BLOOD
    A.  Transport Forms of CO2 in Blood
    B.  Transport Within the Intracellular Compartment
    C.  Transport Across the Erythrocyte Membrane
    E.  Interconversion Between CO2 and HCO3-
    E.  Interconversion Between CO2 and Carbamate
III. CARBON DIOXIDE TRANSPORT IN MUSCLE
    A.  CO2 Production in Muscle
    B.  Localization of CA in Skeletal Muscle
    C.  Transport in the Intracellular Compartment
    D.  Transport Across Sarcolemma
    E.  Transport Across Capillary Walls
IV. KINETIC REQUIREMENTS OF THE PROCESSES INVOLVED IN ELIMINATION OF CARBON DIOXIDE AND LACTIC ACID FROM MUSCLE AND UPTAKE INTO BLOOD
    A.  Theoretical Model of CO2 and Lactic Acid Exchange in Muscle
    B.  Reactions Included in the Model and Their Mathematical Form
    C.  Permeability of the Capillary Wall to Lactate
    D.  Effect of CA at Different Localizations on Equilibration of Intravascular pH, CO2 Excretion, and Excretion of Lactic Acid
V. APPENDIX
    A.  Interstitial Concentrations of CO2, HCO3-, H+, and Lactate
    B.  Concentration Changes Within Plasma and Erythrocytes
    C.  Volumes
    D.  Solutions
    E.  Indexes Used
    F.  Abbreviations and Values of Parameters Used

    ABSTRACT
Top
Next
References

Geers, Cornelia and Gerolf Gros. Carbon Dioxide Transport and Carbonic Anhydrase in Blood and Muscle. Physiol. Rev. 80: 681-715, 2000.CO2 produced within skeletal muscle has to leave the body finally via ventilation by the lung. To get there, CO2 diffuses from the intracellular space into the convective transport medium blood with the two compartments, plasma and erythrocytes. Within the body, CO2 is transported in three different forms: physically dissolved, as HCO3-, or as carbamate. The relative contribution of these three forms to overall transport is changing along this elimination pathway. Thus the kinetics of the interchange have to be considered. Carbonic anhydrase accelerates the hydration/dehydration reaction between CO2, HCO3-, and H+. In skeletal muscle, various isozymes of carbonic anhydrase are localized within erythocytes but are also bound to the capillary wall, thus accessible to plasma; bound to the sarcolemma, thus producing catalytic activity within the interstitial space; and associated with the sarcoplasmic reticulum. In some fiber types, carbonic anhydrase is also present in the sarcoplasm. In exercising skeletal muscle, lactic acid contributes huge amounts of H+ and by these affects the relative contribution of the three forms of CO2. With a theoretical model, the complex interdependence of reactions and transport processes involved in CO2 exchange was analyzed.

    I. INTRODUCTION
Top
Previous
Next
References

One of the major requirements of the body is to eliminate CO2. The large, but highly variable, amount of CO2 that is produced within muscle cells has to leave the body finally via ventilation of the alveolar space. To get there, diffusion of CO2 has to occur from the intracellular space of muscles into the convective transport medium blood, and diffusion out of the blood has to take place into the lung gas space across the alveolocapillary barrier.

Carbon dioxide in the body is present in three different forms: dissolved, bound as bicarbonate, or bound as carbamate. The relative contribution of these different forms to overall CO2 transport changes markedly along this elimination pathway, because for diffusion across membrane barriers, another form is more appropriate than for transport within intra- or extracellular compartments. Thus the kinetics of the interchange between forms become critically important. In addition, the products of one such interchange, the hydration reaction of CO2, HCO3-, and H+, are required for a great variety of other cellular functions such as secretion of acid or base and some reactions of intermediary metabolism. In exercising skeletal muscle, the other "end product" of metabolism, lactic acid, contributes huge amounts of H+ and by these affects the predominance of the three forms of CO2, because HCO3- as well as carbamate are critically dependent on the concentration of H+. Discussion of the overall transport of CO2 in skeletal muscle has to take into account this contribution of lactic acid and its involvement in kinetics and equilibria of CO2 reactions. This interdependence of CO2 and lactic acid elimination is one major aspect of this review, which as far as we know has not before been reviewed in detail.

    II. CARBON DIOXIDE TRANSPORT IN BLOOD
Top
Previous
Next
References

A.  Transport Forms of CO2 in Blood

Carbon dioxide transport forms in blood have been thoroughly reviewed by Klocke (105). We only briefly summarize their respective contribution to overall CO2 exchange. Table 1 sums up the contribution of the various forms in the two compartments plasma and erythrocytes: in whole arterial and venous blood during rest and during heavy exercise.


                              
View this table:
[in this window]
[in a new window]
 
Table 1. CO2 transport in blood at rest and exercise

1.  Dissolved CO2

Only a small portion, ~5% of total arterial content, is present in the form of dissolved CO2. Using a solubility coefficient SCO2 of 3.21 × 10-5 M/Torr (35) for plasma at 37°C, this gives 1.28 mM dissolved CO2, or, using SCO2 of 3.08 × 10-5 M/Torr (7), 1.23 mM dissolved CO2 at a PCO2 of 5.32 kPa (40 Torr). At rest, the contribution of dissolved CO2 to the total arteriovenous CO2 concentration difference is only ~10%. However, during heavy exercise, the contribution of dissolved CO2 can increase sevenfold and then makes up almost one-third of the total CO2 exchange.

2.  CO2 bound as HCO3-

The majority of CO2 in all compartments is bound as HCO3-. The ratio of HCO3- over dissolved CO2 is given by the Henderson-Hasselbalch equation
pH=p<IT>K</IT><IT>′<SUB>a</SUB>+log </IT><FR><NU>[<IT>HCO</IT><SUP><IT>−</IT></SUP><SUB><IT>3</IT></SUB>]</NU><DE><IT>S<SC>co</SC><SUB>2</SUB>×P<SC>co</SC><SUB>2</SUB></IT></DE></FR>
The pKa' has a normal value of 6.10 in human plasma at 37°C and varies with temperature and ionic strength (142). It appears to be slightly different in serum and red blood cells: serum, 6.11; oxygenated erythrocytes, 6.10; deoxygenated erythrocytes, 6.12 (8). During a heavy work load of the muscle, high levels of lactic acid are present in addition to CO2, aggravating the decrease in pH. With this low pH, the fraction of HCO3- in total CO2 is diminished. Although at pH 7.4 HCO3- is 20-fold compared with dissolved CO2, it is only 13-fold at the normal intraerythrocytic pH of 7.2, and the ratio may fall to much lower values at plasma pH values of considerably below 7 during maximal exercise. Therefore, although the absolute arteriovenous difference is higher during exercise than during rest, the relative contribution of HCO3- to overall exchange is less. For the example of heavy exercise given in Table 1, HCO3- contributes only two-thirds of total CO2 exchange, whereas at rest this figure is ~85%.

3.  CO2 bound as carbamate

The amount of CO2 bound as carbamate to hemoglobin in erythrocytes or to plasma proteins depends on O2 saturation of hemoglobin and 2,3-diphosphoglycerate (2,3-DPG) concentration in the case of erythrocytes, and on H+ concentration in the case of both red blood cells and plasma (61, 68, 134, 135). During passage of blood through muscle, O2 saturation and H+ concentration change considerably, in particular during exercise. However, the increase in hemoglobin desaturation and the increase in H+ concentration experienced by red blood cells in the capillary during exercise affect the amount of CO2 bound to hemoglobin in opposite directions. Whereas deoxygenation of hemoglobin increases the amount of CO2 bound to hemoglobin, acidification decreases the amount of carbamate formed by hemoglobin.

To calculate carbamate concentrations within erythrocytes, we use a single set of constants for the alpha - and beta -chains in the oxy state of hemoglobin and separate constants for the alpha - and beta -chains in the deoxy state. Because the calculation of carbamate is dependent on the values of the carbamate equilibrium constant (pKc) and the ionization equilibrium constant of the amino group (pKz) employed, errors in the determination of these constants in different studies can lead to changes in the calculation of the carbamate. Therefore, we use two different sets of constants to give an estimate of the variability of the calculated carbamate concentrations.

For oxyhemoglobin, we use the binding constants of Gros et al. (68) (number of CO2 binding sites per hemoglobin tetramer n = 2, pKc = 4.73, pKz = 7.16), and for deoxyhemoglobin, their constants for the alpha -chain alpha -amino groups of n = 2, pKc = 5.19, pKz = 7.05. However, because their measurements were done in the absence of 2,3-DPG, their carbamate equilibrium constant (Kc) for the alpha -amino groups of the beta -chains of deoxyhemoglobin was not used. On the other hand, intraerythrocytic concentration of 2,3-DPG has effectively no influence on the binding of CO2 to oxyhemoglobin and to the alpha -chain alpha -amino groups of deoxyhemoglobin (132). For the beta -chain alpha -amino group of deoxyhemoglobin, the ionization constant (Kz; pKz = 6.13) estimated by Gros et al. (68) was used in conjunction with the CO2 binding constant lambda  for this same amino group given by Perella et al. (135) for the presence of 2,3-DPG. Perella et al. (135) determined this figure by measuring CO2 binding of hemoglobin whose alpha -amino groups were differentially blocked by cyanate. Using their value of lambda , one obtains together with the above value of pKz a carbamate equilibrium constant pKc = 5.06 for these groups. Thus we describe CO2 binding by the alpha -amino groups of the beta -chains of deoxyhemoglobin in the presence of 2,3-DPG with n = 2, pKz = 6.13, and pKc = 5.06. With these constants we estimate a contribution of only ~5% (0.09 mM) of carbamate to overall CO2 exchange during rest (Table 1). When the pKz and pKc values reported by Perella et al. (134) and the data of Perella et al. (135) are combined in an analogous fashion to estimate binding constants in the presence of 2,3-DPG, a contribution of 9% (0.16 mM) of carbamate to CO2 exchange during rest is calculated. The former estimate of 0.09 mM or 5% agrees nicely with measurements of Böning et al. (13). From their data, an arteriovenous difference for carbamate of 0.09 mM is calculated for the blood gas values of Table 1. It should be noted that all these estimates of the contribution of carbamate to overall CO2 exchange are lower than the value of 12.6% calculated by Klocke (105). However, Klocke's use of the data of Perella et al. (135), which are valid for pH 7.4 rather than the normal intraerythrocytic pH 7.2, may have led to a substantial overestimate of the role of carbamate because carbamate formation increases drastically with increasing pH. Thus it appears that a contribution of 5% by carbamate is a reasonable estimate although markedly lower than previously believed.

During heavy exercise as defined in Table 1, ~6% (10.8% with the data of Perella and co-workers, Refs. 134, 135) of the arteriovenous concentration difference of total CO2 is calculated to be due to a change in carbamate. Böning et al. (13) have measured an ~10% contribution to overall exchange during aerobic exercise, but during heavy exercise with considerable anaerobic metabolism they found that carbamate does not contribute to CO2 exchange at all; arterial blood contained a carbamate concentration that was higher by 0.06-0.13 mol/mol hemoglobin than that of venous blood in the presence of lactic acid. The data of Table 1 thus represent an intermediate position between these extreme types of exercise.

Carbamate concentration in plasma does not contribute to overall CO2 exchange according to Table 1, which is in agreement with Klocke's conclusion (105). During heavy exercise, arterial plasma contains an even higher concentration of carbamate than venous plasma. The physicochemical reason for this is that, in the absence of an oxylabile carbamate fraction as exhibited by hemoglobin, the increase in carbamate by the elevated PCO2 in venous plasma is counteracted or overruled by a decrease in carbamate caused by the fall in pH.

B.  Transport Within the Intracellular Compartment

Figure 1 shows that overall CO2 transport is the sum of the diffusion of 1) dissolved CO2 and 2) CO2 bound as HCO3-. The contribution of HCO3- to CO2 transport is called "facilitated CO2 diffusion" and was first described by Longmuir et al. (111). Gros and Moll (66) and Gros et al. (67) have shown that facilitated CO2 diffusion involves a flux of H+ equivalent to that of HCO3-, a fact which matches the other fact that hydration of CO2 produces equal amounts of H+ and HCO3-. Facilitated CO2 diffusion by HCO3- diffusion under steady-state conditions then requires 1) rapid conversion of CO2 into HCO3- and H+, which at the short diffusion distances as they occur in cells (<1 mm) implies that the presence of carbonic anhydrase (CA) catalyzing CO2 hydration is essential for facilitation to occur, and 2) equal fluxes of H+ and HCO3-, where 3) significant fluxes of H+ can only be achieved when they occur by facilitated H+ diffusion, i.e., by the diffusion of mobile buffers carrying H+ and present at concentrations comparable to that of HCO3-. This leads to the following scheme of facilitated CO2 diffusion shown in Figure 1.



View larger version (45K):
[in this window]
[in a new window]
 
Fig. 1. Mechanism of facilitated diffusion of CO2. White background area indicates free diffusion (physically dissolved) CO2, and the shaded background indicates the process of facilitated CO2 diffusion. "Buffer" is any mobile buffer with an appropriate pK value, such as phosphate at pH ~7.

1.  Diffusion of dissolved CO2

Diffusion coefficients (=diffusion constant/SCO2) have been measured under conditions where only little facilitated diffusion is present. In a 33g% hemoglobin solution, the hemoglobin concentration that prevails inside the red blood cell, the CO2 diffusion coefficient, is reduced to less than one-half of its value in water (Table 2). It is not clear why the figure of Uchida et al. (173) is three times lower than the figure of Gros and Moll (64) for this condition. Compared with diffusion in water, diffusion is hindered by the presence of hemoglobin as it is by the presence of other intracellular proteins. It appears that proteins are virtually impermeable to CO2 and represent the major obstacles to CO2 diffusion within cells (64). Accordingly, CO2 diffusion constants decrease in a defined manner with increasing hemoglobin concentration (curve in Fig. 2) that can be explained quantitatively on the basis of the geometry of the water space in a hemoglobin solution (64). Similarly, the CO2 diffusion constant in various tissues varies systematically with the protein concentration of these tissues (points in Fig. 2). It is obvious that, for a given protein concentration, the CO2 diffusion constants in these different cells or tissues agree very nicely.


                              
View this table:
[in this window]
[in a new window]
 
Table 2. Diffusion coefficient of dissolved CO2 in water and hemoglobin solutions



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2. Diffusion constants of CO2 (in cm2·min-1·atm-1) at 22°C in different tissues as a function of the protein concentration (points) and in hemoglobin solutions of different hemoglobin concentrations (solid line). [Redrawn from Gros and Moll (64).]

2.  Diffusion of HCO3-

The diffusion coefficients for HCO3- are about one-half as great as those for CO2, and in the presence of proteins, its diffusion can be expected to be hindered to an extent comparable to that observed for CO2 diffusion. The HCO3- diffusion coefficient is calculated from the equivalent conductivity of HCO3- (67, 108), 11.7 × 10-6 cm2/s in pure water at 25°C, and is reduced to 8.7 × 10-6 cm2/s at physiological ionic strength and 25°C (67). Again, Uchida et al. (173) report a surprisingly low value of 1.4 × 10-6 cm2/s for HCO3- diffusion in "100% hemolysate" at 37°C. The relative contribution of HCO3- to total CO2 diffusion (=facilitated diffusion) can be evaluated on the basis of these diffusion coefficients. The contribution of HCO3- diffusion, and thus of facilitated diffusion, to total CO2 diffusion depends greatly on the partial pressure range of CO2 in which the transport process takes place. This can be predicted from the general shape of CO2 binding curves, which are steep at low PCO2 values and become flatter with increasing PCO2. Therefore, the HCO3- concentration gradient per CO2 concentration gradient is higher at low PCO2, and vice versa. This implies that the relative contribution of facilitated diffusion is highest at lowest PCO2 values and decreases consistently with increasing PCO2 (66, 67).

3.  Diffusion of H+

The diffusion coefficient of free H+ in aqueous solutions at 25°C is 9.3 × 10-5 cm2/s (123), i.e., H+ possess a more than five times greater diffusivity in water than CO2. Nevertheless, free diffusion of H+ is a rather ineffective mechanism of H+ transport, because at physiological values of pH, the H+ concentration gradients within cells cannot exceed the order of 10-7 to 10-8 M. In the presence of buffering substances at physiological concentrations of 10-3 to 10-2 M, such differences of free H+ concentrations are accompanied by concentration differences of buffered H+ of at least of 10-3 to 10-2 M or more. This very much higher concentration difference of the bound H+ compensates for the lower diffusion coefficients of mobile buffers. The diffusion coefficient for a mobile buffer such as phosphate is of the same order of magnitude as that of HCO3-, 7.0 × 10-6 cm2/s (67). Consider as an example an intracellular pH difference of 0.1 between absolute pH values of 7.1 and 7.2; then, the expected flux of H+ by free H+ diffusion, estimated as diffusion coefficient (D) × concentration difference (Delta c), gives 9.3 × 10-5 × 1.62 × 10-8 mmol·cm-1·s-1 = 1.5 × 10-12 mmol·cm-1·s-1. Estimating facilitated H+ flux by diffusion of buffered H+ with the assumption of a buffer capacity of 40 mM/Delta pH and the above value of D for phosphate in an analogous fashion yields 7.0 × 10-6 × 0.1 × 40 × 10-3 mmol·cm-1·s-1 = 2.8 × 10-8 mmol·cm-1·s-1. Thus facilitated H+ diffusion by buffer diffusion in this example is more than 10,000 times more effective than free diffusion of H+. It has been shown that not only the diffusion of low-molecular-weight buffers such as phosphate (67) but also the diffusion of protein buffers (66) is a highly effective means of H+ transport. In the case of very large protein molecules, it has even been shown that facilitated H+ transport occurs very efficiently not only by translational but in addition by rotational protein diffusion (62, 63). Thus facilitated CO2 diffusion essentially occurs by diffusion of HCO3- and simultaneous buffer-facilitated H+ diffusion. That buffer mobility is indispensable for this process to take place has been shown by Gros et al. (67) by demonstrating that immobilized phosphate buffer cannot entertain facilitated CO2 diffusion.

Al-Baldawi and Abercrombie (3) have reported measurements of H+ diffusion in cytoplasm extracted from giant neurons of a marine invertebrate. An apparent diffusion coefficient for H+ of only 1.4 × 10-6 cm2/s was determined, which was 5 times lower than the estimated diffusion coefficient of the mobile buffers and 70 times lower than the diffusion coefficient of free H+. This appears to be in contradiction to the above considerations. However, because the authors performed their measurements under non-steady-state conditions by observing the relaxation of pH after a sudden pH change at one surface of the cytoplasm sample, it appears likely that this value represents a substantial underestimate of the apparent H+ diffusivity that one would observe under steady-state conditions. A pH transient will be greatly slowed down by the presence of buffers whose buffering capacity is so overwhelming compared with free H+ concentration. This problem was aggravated in the experiments of Al-Baldawi and Abercrombie (3) by the presence in the cytoplasm of a substantial fraction of immobile buffers.

The contribution of facilitated diffusion to overall diffusion depends on the actual concentration differences for HCO3- and for buffered H+. These in turn are dependent on the actual pH gradient and the pK value(s) of the mobile buffer(s) present. As an example, calculated CO2 fluxes are shown in Figure 3 as a function of the average pH with boundary PCO2 values of 5.32 and 6.65 kPa (40 and 50 mmHg) in a 66 mM phosphate solution (pK 6.84, 25°C). Total CO2 diffusion is more than twice as high as free diffusion of dissolved CO2 in a pH range of ~6.9-7.8. Thus more than one-half of the CO2 transport in this model system occurs by facilitated diffusion, which means that at a physiological pH of the intracellular or extracellular spaces more HCO3- than CO2 molecules contribute to total CO2 flux within the compartment. Facilitated diffusion does not reach its maximum exactly at the pK value of the phosphate, i.e., at the maximal buffer capacity of the solution. The reason for this is that whereas above pH 6.84 the buffer capacity decreases, the pH difference across the layer increases markedly. The sum of these two effects leads to an increase with increasing pH in the concentration differences of HCO3- and of the H+-carrying H2PO4- beyond the pK of the phosphate buffer. Under physiological conditions, the course of this curve may be different, since buffering is accomplished by different sets of buffers with more than one pK value. Although proteins, which are important buffers in intact cells, possess a lower diffusivity than inorganic phosphate, their large buffer capacity for H+ results in a facilitation of CO2 diffusion in intact cells that is of a similar order of magnitude as shown in Figure 3 for phosphate. For the condition within red blood cells, in a hemoglobin solution of 30 g% Hb at 38°C and at roughly physiological pH and PCO2, Gros and Moll (65) have measured a contribution of facilitated CO2 diffusion of ~85% to total intraerythrocytic CO2 transport.



View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3. Calculated CO2 fluxes across a layer of buffer solution as a function of the average pH value in this layer. The boundary CO2 partial pressures are constant with 6.65 and 5.32 kPa (50 and 40 mmHg), respectively. The solution is 66 mM phosphate with varying contents of base. Thickness of the layer is 180 µm. Carbonic anhydrase is assumed to be present in excess. Solid curve represents the total flux of CO2, and dashed curve represents the flux by free diffusion only. [Redrawn from Gros et al. (67).]

C.  Transport Across the Erythrocyte Membrane

Although total CO2 flux across the membrane can again be considered as the sum of diffusion of dissolved CO2 and of HCO3- with accompanying H+, the relative contributions of dissolved and bound CO2 to overall CO2 flux across the erythrocyte membrane are quite different compared with diffusion within the intracellular compartment.

1.  Dissolved CO2

Cell membranes are generally considered to be highly permeable to gases such as CO2 or O2, with one of the few exceptions being the apical membrane of parietal and chief cells of gastric glands, which have been described to possess "no detectable permeability to NH3, NH4+, CO2, and HCO3-" and whose surface area times permeability product was found to be about three orders of magnitude lower than that of the basolateral membranes of the same cells (15, 176). Erythrocyte membranes, though, are highly permeable to CO2, the absolute permeability values cited being in the range of 0.35-3 cm/s (Table 3), as has been thoroughly discussed by Klocke (105). More recently, Forster et al. (47) measured the rate of depletion of C16O18O in erythrocyte suspensions by mass spectroscopy. They evaluated their measurements to give the CO2 permeability of the human red cell membrane and obtained a value of ~1 cm/s. If we simplistically equate physiological CO2 concentration with CO2 concentration difference across the membrane (cCO2), we can estimate the possible order of magnitude of physiologically occurring CO2 fluxes from PCO2 × cCO2 = 1 cm/s × 1 mM = 1 × 10-3 mmol·cm-2·s-1.


                              
View this table:
[in this window]
[in a new window]
 
Table 3. Permeability of erythrocytic and other membranes

2.  HCO3-

Permeability for HCO3- of artificial phospholipid vesicles, which are devoid of any anion exchanger, is six orders of magnitude lower (Table 3; Ref. 127) than it is for dissolved CO2. However, erythrocyte membranes of all vertebrates with the exception of agnathans (hagfishes and lampreys; see reviews, Refs. 80, 126, 136) do have a rapid anion (HCO3-/Cl-) exchange protein, capnophorin or band 3 (see review by Jennings, Ref. 90), which exchanges HCO3- for Cl- at a ratio of 1:1. An overview of the distribution of this transporter in red blood cells is given in Table 4. Thus the permeability of the erythrocyte membrane to HCO3- is considerably increased over that of lipid bilayers but still about three to four orders of magnitude lower than the permeability for dissolved CO2 (Table 3). Net driving force for HCO3-/Cl- exchange is proportional to the difference in the electrochemical potential for both ions. The turnover number of this transporter is 4-5 × 104 Cl-·s-1·transporter molecule-1 at 37°C (16, 56). With this figure and the number of 1.0-1.2 × 106 copies of capnophorin per red blood cell (90), a maximal flux across the membrane of ~6 × 10-5 mmol Cl-·cm-2·s-1 can be calculated using an erythrocytic volume of 80 × 10-12 cm3 and a red cell surface of 1.6 × 10-6 cm2. Maximal HCO3- flux is expected to be in the same range as that of Cl-. Flux measurements at 0°C have shown a maximal value for HCO3- flux of 1% of this theoretical value, ~5 × 10-7 mmol HCO3-·cm-2·s-1 (48). When the large temperature dependence of the anion transporter with a turnover number at 0°C of only ~200 Cl-·s-1·molecule-1 (56) is taken into account, this agrees well with the value calculated above for maximal flux at 37°C. Values of HCO3- permeability of erythrocyte membranes are similar for humans and birds (as well as in several other species). In red blood cells of adult humans and of chicken HCO3- permeability (PHCO3-) was measured to be 5.6 × 10-4 and 7 × 10-4 cm/s, respectively (160). These latter authors showed that a functionally active band 3 protein is present in the erythrocyte membrane of the chicken at very early stages of development. In the dogfish (Mustelus canis), flux of HCO3- across red cell membrane was reported to equal flux across human red cell membranes (128). It should be mentioned that a very large number of measurements have been reported for the HCO3- permeability of the human red blood cell (e.g., Refs. 19, 30, 88, 103), most of which yielded numbers very similar to that of Sieger et al. (160), as cited in Table 3. Estimating the physiologically possible HCO3- flux across the red cell membrane in a fashion analogous to that used above for CO2, one obtains the following: PHCO3- × cHCO3- = 5 × 10-4 cm/s × 10 mM = 5 × 10-6 mmol·cm-2·s-1, which is ~10 times less than the maximal flux of 6 × 10-5 mmol·cm-2·s-1 estimated above from turnover number and number of copies of capnophorin per red blood cell but more than two orders of magnitude smaller than the above CO2 flux.


                              
View this table:
[in this window]
[in a new window]
 
Table 4. Carbonic anhydrase activity and HCO3-/Cl- exchanger in blood of different species

3.  H+

Proton permeability of phospholipid vesicles is five times higher than HCO3- permeability, 1.8 × 10-5 cm/s (127). However, because the H+ concentration gradient across the cell membrane is very small (intracellular pH 7.2, extracellular pH 7.4, Delta pH 0.2), the product permeability × concentration gradient, is also very small: PH+ × cH+ = 1.8 × 10-5 cm/s × 2.3 × 10-8 M = 4 × 10-13 mmol H+·cm-2·s-1. Thus diffusion of free H+ across the membrane is so small that it cannot support any facilitated CO2 diffusion. However, in addition to free H+ diffusion, there are several other more efficient mechanisms of H+ transport across the red cell membrane. The significance of these pathways for overall H+ flux across the erythrocytic membrane depends on the specific conditions. Proton fluxes (or reverse OH+ fluxes) in erythrocyte membranes can be achieved via 1) the Jacobs-Stewart cycle, which includes HCO3-/Cl- exchange via capnophorin; 2) H+ flux via HCl cotransport (or OH+-Cl- countertransport); and 3) H+ flux via H+-lactate cotransport and nonionic lactic acid diffusion.

Bisognano et al. (12) measured H+ fluxes across red cell membranes by a pH stat method. They induced these fluxes by establishing an outward Cl concentration gradient through increasing the osmotic strength of the extracellular solution with sucrose. Without lactate/lactic acid present, two-thirds of the measured apparent H+ flux was mediated via the Jacobs-Stewart cycle (89), and one-third was due to a DIDS-sensitive HCl cotransport. The Jacobs-Stewart cycle brings about a H+ efflux from the red blood cell by the following sequence of processes: 1) H+ in the cell reacts with HCO3- to give CO2, 2) CO2 leaves the cell and 3) is hydrated extracellularly to give H+ and HCO3-, where 4) the H+ remains outside while the HCO3- enters the cell in exchange for Cl- via the Cl-/HCO3- exchanger. Bisognano et al. (12) base their study on the assumption that the Jacobs-Stewart cycle-mediated H+ flux is inhibitable by the CA inhibitor ethoxzolamide, whereas HCl cotransport is not affected by this drug but suppressed by DIDS. Under their conditions, an initial flux via HCl cotransport was observed at 0.5 × 10-9 mmol H+·cm-2·s-1, compared with 1 × 10-9 mmol H+·cm-2·s-1 mediated by the Jacobs-Stewart cycle, giving a total H+ flux by these two mechanisms of 1.5 × 10-9 mmol·cm-2·s-1.

Compared with free H+ diffusion, this value is very high; it is considerably lower than the HCO3- flux estimated above and substantially lower than the estimated CO2 flux.

A third mechanism of H+ transport across the red cell membrane is by the H+/lactate carrier and by nonionic diffusion of lactic acid, both of which require the presence of lactate (27, 138). Proton fluxes via this mechanism were calculated from flux measurements of Fishbein et al. (42) and of Poole and Halestrap (138) in human red blood cells to be 2-2.5 × 10-9 mmol H+·cm-2·s-1. Thus, in the presence of lactate, the above H+ flux estimate would have to be raised to ~4 × 10-9 mmol·cm-2· s-1, which is much lower than the flux estimate for HCO3-. The fluxes of both ions, however, are more than two orders of magnitude smaller than a physiological CO2 flux. Thus a significant facilitation of CO2 diffusion across the red cell membrane does not occur. It may be noted that the activity of the H+-lactate cotransport can be increased considerably in Plasmodium falciparum-infected human erythrocytes (96).

In conclusion, the permeability of dissolved CO2 is much greater than the effective permeability of HCO3- and H+. At the same time, more than two-thirds of the CO2 transported in either red blood cells or plasma is transported in the form of HCO3-. This makes it appear essential that CO2 and HCO3- can be converted into each other quite rapidly at the boundary between the two compartments: intraerythrocytic space and plasma. A high velocity of this interconversion is achieved by the enzyme CA.

Although HCO3- and H+ are produced in equal amounts by the hydration of CO2, the distribution of the two products among the two compartments, intraerythrocytic space and plasma, is quite different at electrochemical equilibrium. Bicarbonate is transported to a larger fraction within plasma than within erythrocytes because the equilibrium pH of the plasma is more alkaline than the intraerythrocytic pH (Table 1). In contrast, H+ are transported to a larger fraction within erythrocytes than in plasma because the nonbicarbonate buffer capacity of erythrocytes exceeds that of plasma by a factor of ~10.

The CO2 entering the blood during capillary passage through the peripheral tissue can encounter two different situations: 1) a situation where CA is present in red blood cells only, or 2) a situation where CA is available in red blood cells and in plasma,

A) RAPID CATALYSIS OCCURS ONLY WITHIN ERYTHROCYTES. Carbon dioxide enters the red blood cells, and there is rapidly converted to HCO3- and H+. When the red blood cell has reached the end of the capillary, electrochemical equilibrium across erythrocyte membrane is not yet established, because H+ concentration and even more so HCO3- concentration are too high within red blood cells compared with plasma concentrations. A significant fraction of the intraerythrocytic HCO3- has left the cell via HCO3-/Cl- exchange already during capillary transit. After blood has left the capillary, part of HCO3- and H+ that has been produced within the red blood cell is dehydrated back to give CO2; CO2 then leaves the cell and enters the plasma, where the slow uncatalyzed reaction hydrates CO2 to establish final equilibrium. During this postcapillary process, the plasma pH shifts slowly in the acidic direction.

B) RAPID CATALYSIS OCCURS IN ERYTHROCYTES AND IN PLASMA. Carbon dioxide enters red blood cells and is rapidly converted there, but also within plasma, to HCO3- and H+. Equilibration between the two compartments is no longer rate limited by the slow CO2 hydration reaction in plasma. The pH of the blood leaving the capillary can be expected to be constant and in equilibrium. However, as is shown in section IVD2, in the presence of lactic acid production in the tissue, this must not necessarily be so. At the end of capillary transit, it may even be possible that H+ concentration in plasma is too high compared with intraerythrocytic concentration for equilibrium to be established across the erythrocytic wall, since equilibration of lactic acid across this wall is a slow process.

For CO2 excretion, it is essential that there is a rapid chemical reaction of CO2. However, how and how fast acid-base equilibrium is established in the blood depends on the sites of CA localization and its activity. This and the velocity of other CO2 reactions will therefore be considered in the following sections.

E.  Interconversion Between CO2 and HCO3-

The interconversion between CO2 and HCO3- without a catalyst is rather slow and may require more than 1 min to approach completion, a time much too long compared with the capillary transit time, which is ~1 s. Carbon dioxide hydration/dehydration reactions are accelerated between 13- and 25,000-fold by intraerythrocytic CA activities (46, 47). With such a CA activity, the interconversion between CO2 and HCO3- inside erythrocytes requires only 2 ms for 95% completion.

The participants of this reaction, HCO3- and, in particular, the H+ (see sects. IIIC1, IIID, and IV) are involved in other reactions, so the time course of their concentration is also dependent on the kinetics of other reactions. For a complete understanding of the overall time course of CO2 exchange, these reactions have also to be considered.

1.  Catalysis by CA in blood

Carbonic anhydrase is found in the blood of all vertebrates. With respect to location, isozyme types, and coexpression of the anion exchanger (capnophorin), there are very interesting variations between different species from the lower vertebrates to mammals (Table 4) that may shed light on the increasing efficiency of CO2 excretion in the course of evolution.

A) CYTOPLASM OF ERYTHROCYTES. Carbonic anhydrase was first detected by Meldrum and Roughton (118) [for review, see Maren (113) and Klocke (105)]. Briefly, isozyme CA I with a relatively low specific activity occurs in the red blood cells of all vertebrate groups with the exception of the cat family and a few other species; it is absent in the red blood cells of the cat, lion, jaguar, tiger, leopard, ox, chicken, and frog (18, 115). In primitive agnathans (lamprey, hagfish) and elasmobranchs (dogfish), CA I is the only isozyme present (114). It is somewhat less inhibitable by sulfonamides and considerably more susceptible to anions than CA II. Isozyme CA II with a specific activity that is ~10 times higher than that of CA I is probably the most widespread form and occurs in the red blood cells of all vertebrates except agnathans and elasmobranchs.

A mechanism for rapid HCO3-/Cl- exchange across the erythrocyte membrane is present in almost all vertebrate red blood cells and is missing only in the most primitive vertebrate group, the agnathans (lamprey, hagfish; Refs. 39, 131, 171, 172). The consequence of this has been discussed by Nikinmaa (126). In these fish this precludes the utilization of plasma HCO3- in CO2 excretion on a physiological time scale. Together with the rather flat CO2 binding curve, CO2 transport in these animals appears rather inefficient, yet in the lamprey, CO2 transport potential is as great as in the highly active teleosts despite the missing anion exchanger. In this species, the disadvantage is overcome by a high intraerythrocytic pH, resulting in a high intracellular binding capacity for CO2 and a marked Haldane effect. However, the intracellular buffering capacity is separated from the plasma compartment in lampreys due to the low membrane permeability to HCO3-. As a consequence, extracellular metabolic acid loads cause marked fluctuations in plasma pH. Thus the major advantage gained by the rapid anion exchanger appears to consist of an improved effective extracellular buffering (with access to the intracellular buffering power) rather than in a major improvement of gas transport (126).

The acceleration of the hydration-dehydration velocity by CA within erythrocytes is considerable. An activity (factor by which the rate of CO2 hydration is accelerated) of 13-14,000 was reported by Forster and Itada (46), and figures of 23,000 and 25,000 have been obtained by Wistrand (184) and by Forster et al. (47). The cytosolic CA enzymes may be not uniformly distributed within the red blood cells. Some indications have been proposed to suggest that their concentration may be increased near the cellular border. Interactions of CA are reported with the plasmalemmal anion exchanger (capnophorin = band 3; Ref. 98), and it would seem a most efficient place to catalyze CO2-HCO3- hydration-dehydration reaction in close neighborhood to HCO3-/Cl- exchange. Parkes and Coleman (133) reported an enhancement of CA activity by erythrocytic membranes; CA II and CA I activity were increased 3.5- and 1.6-fold, respectively, by the presence of red cell membranes. Whether in their erythrocytic membrane preparation the effective structure was the band 3 protein can only be speculated. Although these observations have not been confirmed yet by other investigators, there are several studies of the problem whether part of red cell CA is firmly bound to the erythrocyte membrane. Whereas Enns (40) had found CA in red cell ghosts, later studies by Tappan (170), Rosenberg and Guidotti (145), and Randall and Maren (139) came to the conclusion that red cell CA is a truly cytosolic enzyme and not membrane bound.

B) PLASMA. No CA activity aside from that attributable to lysed erythrocytes was ever found in plasma, with the sole exception of dogfish (Scyliorhinus canicula; Ref. 186). Also, there is no CA activity on the outside surface of erythrocytes or available to plasma, as was confirmed by Effros et al. (37).

However, in tissues where especially large amounts of CO2 leave or enter the blood, there is extracellular catalysis available to the capillary plasma in some species. This is achieved by an extracellular CA bound to membranes, the membrane-bound isozyme CA IV, which provides catalytic activity to the plasma. Such a membrane-bound CA was found in the lung (36, 104, 150) and gill (28). In skeletal muscle, the first evidence for the presence of such a CA in dog, cat, and rabbit was provided by measurements of the distribution space of labeled HCO3- (37, 50, 51, 189) and by measurements of the postcapillary pH kinetics (128).

With the histochemical method of Hanson, staining of endothelial membranes as well as sarcolemma was observed in skeletal muscle (140, 141). Immunohistochemical studies employing anti-CA IV antibodies at the light microscopic level revealed staining of capillary walls, which would indicate that CA IV is associated with endothelial cell membranes (157). With the use of semithin sections and a more sensitive immunocytochemical technique, however, capillaries and sarcolemma were found to be stained, and in antibody-treated ultrathin sections of skeletal muscle studied by electron microscopy, membrane-bound CA IV was found to be associated with capillary endothelium, sarcolemma, and sarcoplasmic reticulum (SR) (24). That sarcolemmal and SR CA IV were visible in ultrathin sections but not in cryosections was attributed to a poor accessibility of CA IV at these locations in the 7-µm-thick untreated cryosections. Another approach has been used by Geers et al. (51). Measuring the space of distribution of labeled HCO3- and its reduction by CA inhibitors, Geers et al. (51) observed that the effectiveness of macromolecular CA inhibitors of different molecular size (Prontosil-dextrans of mol wt 5,000 vs. 100,000) indicates the presence of CA in the interstitial space. Indirect although strong evidence for this CA to be associated with the sarcolemma was obtained by intracellular and cell surface pH microelectrode measurements on skeletal muscle fibers by deHemptinne et al. (25). They observed a transient alkaline pH shift on the surface of these fibers upon exposure to propionate, whose magnitude was greatly increased in the presence of the CA inhibitor acetazolamide in the extracellular space. This was interpreted to show that in the presence of extracellular sarcolemmal CA CO2-HCO3- acts as a rapid and efficient source of H+ that enter the cells together with the propionate ion. Analysis of isolated sarcolemmal vesicles demonstrated the presence of high activities of CA associated with the sarcolemma (179), and it was shown by Western blotting with anti-CA IV antibody that this sarcolemmal CA is isozyme CA IV (175). In conclusion then, the present state of evidence indicates that in skeletal muscle, membrane-bound CA IV is associated with endothelial as well as with sarcolemmal membranes, in addition to a CA bound to the sarcoplasmic reticulum membrane.

In the case of lung tissue, it was estimated by Bidani et al. (11) that the CA of rat pulmonary vasculature catalyzes the extracellular hydration-dehydration reaction by a factor of 130-150, a figure that may appear rather small compared with the intraerythrocytic activity of >10,000. However, the calculations described below indicate that an activity of 100 in the plasma within the capillary bed of skeletal muscle should be sufficient physiologically (see sect. IVD2). No estimates of intracapillary CA activity in muscle capillaries are available.

The localization pattern of CA in blood is further complicated by the presence of a CA inhibitor in the plasma of some species, which ensures the absence of any activity of soluble CA in plasma. This was first described for dog and fish (14) and later for pig, sheep, rabbit, and various fish species (74, 75, 77, 83, 109, 137, 149). The molecular size of this endogenous CA inhibitor was determined to be 10-30 kDa for the eel (74) and 79 kDa for the pig (148).

In view of the presence of an extracellular membrane-bound CA activity available to plasma in lung and muscle, the existence of a plasma CA inhibitor seems astonishing. However, some experiments indicate that the plasma inhibitor inhibits erythrocytic cytosolic CA rather well, but CA from lung tissue homogenate (membrane-bound CA; dog) only incompletely (83). Similarly, plasma inhibitor from pigs showed a less than complete inhibition of vascular CA activity in lungs of rats (78), where the vascular activity of CA is known to be CA IV located on the extracellular luminal surface of capillary endothelial cells.

It may be hypothesized that, due to its molecular size, the plasma inhibitor has no access to the interstitial space. Thus a CA associated with the sarcolemma may be left uninhibited by the plasma inhibitor, because a macromolecule of this size may not enter the interstitial space to a great extent. Even the endothelial membrane-bound CA IV in the lung appears to be only partly inhibited, and this should also be true for capillary CA IV of muscle (and, for example, of the brain).

We conclude that the plasma inhibitor will inhibit erythocytic CA released from any hemolyzed red blood cells throughout the blood vessels rather completely, thus reducing the dehydration/hydration reaction in the plasma to the uncatalyzed velocity, whereas in vascular regions with a membrane-bound CA, e.g., muscle, heart, lungs, and others, a marked catalysis of the dehydration/hydration reaction can take place even in the presence of a plasma inhibitor. Thus CA activity available to plasma appears to be confined to precise localizations within the circulation that are equipped with a capillary CA.

The effect of presence of CA in the plasma has been studied by Wood and Munger (186) for the rainbow trout. They found that CA attenuated postexercise increases in PCO2 and decreases in arterial pH by producing an increase in CO2 excretion during exercise. However, the normal postexercise hyperventilation was also greatly attenuated when CA was present in the plasma, as was the normal increase in the plasma levels of epinephrine and norepinephrine. They concluded that CO2 is an important secondary drive to ventilation in fish, and by increasing CO2 excretion by the presence of CA in the plasma this drive is diminished. The plasma CA inhibitor will ensure that no CA activity of hemolysed erythrocytes is present and thus will contribute to maintain a high level of ventilation in certain situations, which will be favorable for O2 supply.

E.  Interconversion Between CO2 and Carbamate

The kinetics of oxylabile carbamate was thoroughly reviewed by Klocke (105). We only briefly summarize the relevant facts in these sections.

1.  In plasma

The kinetics of this interconversion do not seem to be important for overall CO2 kinetics, since venous and arterial plasma carbamate concentrations are almost identical. The kinetics of plasma carbamate formation were characterized by Gros et al. (61) by a half-time of this reaction of 0.047 s.

2.  In erythrocytes

The binding of CO2 to hemoglobin in solution has long been known to be quite rapid, requiring a time to reach completion of 0.1-0.2 s (44), which corresponds to a half-time of ~0.04 s. Gros et al. (68) have studied the kinetics of hemoglobin carbamate formation in a wide range of pH and PCO2 values using a pH stopped-flow technique. They determined kinetic constants for the forward reaction of amino groups and CO2, ka, for the alpha -chain and the beta -chain alpha -NH2 groups in addition to the e-NH2 groups of human oxy- and deoxyhemoglobin. Table 5 shows the complete set of constants reported by Gros et al. (68) with ka, pKz, and pKc, which describe their kinetic measurements. With these constants, overall carbamate kinetics under physiological conditions of pH and PCO2 were estimated to possess a half-time of 200 ms and to require ~1 s to reach equilibrium by 95%. Their measurements were performed in the absence of 2,3-DPG, and these times may become slightly shorter when 2,3-DPG is present. Nevertheless, their estimate of the half-time of carbamate formation is considerably greater than that of Forster et al. (44) but is similar to Klocke's estimate (102) of the half-time of mobilization of oxylabile carbamate of 0.12 s, which was obtained in the presence of 2,3-DPG.


                              
View this table:
[in this window]
[in a new window]
 
Table 5. Velocity constants, ka, and equilibrium constants for carbamate reactions of human hemoglobin

    III. CARBON DIOXIDE TRANSPORT IN MUSCLE
Top
Previous
Next
References

A.  CO2 Production in Muscle

Unlike most other tissues, muscle exhibits a vast range of aerobic (and anaerobic) metabolic rates. In humans, O2 consumption of muscle tissue can rise 15- to 20-fold from resting values of ~10 µmol·min-1·100 g-1, and even higher increases have been reported from 6.3 mmol·min-1·100 g-1 at rest to 200 µmol·min-1·100 g-1 at maximal exercise of a small muscle group (forearm; Ref. 73). Carbon dioxide production rates can be calculated from these O2 consumption rates using a RQ of ~0.85. The PCO2 values in the venous blood leaving the skeletal muscle have also been measured and are ~5.32-5.99 kPa (40-45 mmHg) at rest and can rise to as much as ~13.3 kPa (100 mmHg) during exercise (for example, Ref. 95).

Although different muscle types and different mammalian species have vastly different maximal specific O2 consumption rates, maximal specific mitochondrial O2 consumption differs considerably less. At maximum O2 consumption (VO2max), mitochondria of different species consumed 4.56 ± 0.61 ml O2·min-1·ml-1 (87). This indicates that it is essentially mitochondrial density in muscle fibers that determines maximal specific O2 consumption of these fibers.

Carbon dioxide produced within muscle mitochondria has to diffuse through the intracellular compartment and cross the sarcolemmal membrane and the capillary wall to reach the convective medium blood. Because all the membranes crossed by CO2 along this diffusion pathway are considered highly permeable to CO2, their surface area is of no relevance for CO2 transport, but this area may be important for the permeation of ions associated with gaseous exchange. Among these membrane barriers, the capillary wall has by far the smallest surface area, only ~1/5 of the entire area of the sarcolemma (185) and only ~1/200 of the total area of the inner mitochondrial membranes (87). The following fluxes of respiratory gases occur across the surface of the capillary wall. Maximal flow of O2 per area of capillary wall is 1.3-1.9 µl O2·min-1·cm-2 as calculated from Conley et al. (20), where the higher values have been measured in more athletic species (dog, pony) and the lower values in less athletic ones (goat, calf). Corresponding maximal total CO2 flux across capillary wall can be expected to be ~15% lower than the respective O2 fluxes (~60 nmol CO2·min-1·cm-2). The area of inner mitochondrial membranes being larger, CO2 flux across this membrane is expected to be ~0.3 nmol CO2·min-1·cm-2. This may indicate that the capillary wall could be a significant barrier to ion fluxes associated with CO2 transport.

B.  Localization of CA in Skeletal Muscle

As discussed for erythrocytes, dissolved CO2 gas with few exceptions is highly permeable across biological membranes, but the more abundant species, HCO3-, is not. This permeability difference requires conversion of HCO3- to CO2 at a sufficient speed in red blood cells as well as in muscle cells before permeation of the membrane occurs, and only CA can ensure this rapid conversion.

Several types of CA are present in various parts of skeletal muscle as has been reviewed by Gros and Dogson (60) and recently by Henry (79). Table 6 gives a summary of CA localizations in skeletal muscle.


                              
View this table:
[in this window]
[in a new window]
 
Table 6. Localization of carbonic anhydrase in skeletal muscle

1.  Capillary endothelium

As discussed in section IID, there is clear evidence that skeletal muscle capillaries possess an endothelial membrane-bound CA. The evidence that this enzyme is CA IV appears convincing.

2.  Sarcolemma

Carbonic anhydrase associated with this membrane was found with a variety of methods. The first evidence for the presence of an extracellular catalysis of the hydration/dehydration reaction in the capillary bed of skeletal muscle arose from functional studies. From observation of the distribution space of H14CO3- and its reduction in the presence of CA inhibitors, it was concluded that an extracellular CA in mammalian skeletal muscle exists (38). Its inhibition properties were different from those of the cytosolic enzymes, and it was concluded that this isozyme is present in the interstitial space and probably bound to the sarcolemma (50, 51). Other functional studies have indicated that an extracellular CA available to plasma is involved in fast pH equilibration of the venous effluent and the interstitial space. With the use of a stop-flow technique, it was shown that an electrolyte perfusate had access to a CA while it passed through the hindlimb capillary bed. By inhibiting this extracellular CA, a pH disequilibrium developed in the venous saline perfusate, and the pH of the effluent slowly became more acidic after the saline had left the capillary bed, i.e., a so-called postcapillary acid pH shift developed (129). It appears likely now that these effects, at least partly, are due to capillary endothelial CA IV.

Transient changes of surface pH, induced by sudden addition and withdrawal of propionic acid, were magnified when CA was inhibited in isolated soleus muscle from mouse and rat and in cardiac muscle from sheep, rabbit, and cat (25). Transient changes of surface pH induced by a sudden increase and decrease of PCO2 were blocked by CA inhibitors in a nonvertebrate muscle, the crayfish muscle (151). In the former case, surface pH change is due to a net movement of H+ across the membrane together with propionate. When sarcolemmal CA is blocked, the efficacy of the CO2/HCO3- buffer is diminished, producing an increased pH transient. In the latter experiment, inhibition of the sarcolemmal CA activity leads to a suppression of surface pH transients that are caused by net fluxes of CO2, which go along with rapid changes in surface PCO2 that are followed by H+ production or consumption when CA is present on the cell surface, but are not (or very slowly) when CA is inhibited. These effects are clearly due to a CA bound to the external surface of muscle fibers.

In sarcolemmal vesicles, a CA was found in preparations from red and from white muscles of the rabbit. The inhibition constants (Ki) of this sarcolemmal CA toward acetazolamide, chlorzolamide, and cyanate were shown to be different from those of CA II or CA III (179). With CA IV antibodies this sarcolemmal CA was identified to be CA IV (175). In semithin and ultrathin sections of rat soleus muscle, CA IV was found immunocytochemically to be associated with the sarcolemma in addition to its association with the capillary endothelium and the SR (24). In mammalian heart, CA IV was also found to be associated with the sarcolemma in addition to the capillaries (156). Thus the present state of information indicates that sarcolemmal CA is the membrane-bound, glycosyl-phosphatidylinositol (GPI)-anchored isoform CA IV.

3.  Cytoplasm

It is well known that the sulfonamide-resistant isozyme CA III is present in high concentration in the cytoplasm of mammalian skeletal muscle type I (slow-oxidative fibers) (review, Ref. 60). A sulfonamide-sensitive CA, probably CA II, was found in the cytosol of white muscles of the rabbit (161) and in the mouse soleus (21). In the latter case, however, no measurements of the erythrocytic contamination of the muscle homogenates were done; thus CA II of erythrocytes could be present in these experiments. In contrast, in the former case, red cell contamination was carefully controlled. In the cytoplasm of white as well as red hindlimb muscles of the rat, no sulfonamide-sensitive CA was present (54). For other animal groups, studies are scarce; from functional studies, the presence of a CA in the cytosol of crayfish muscle was deduced (151), and there is one report indicating that frog white muscle has a CA II-type isozyme (155).

Mammalian heart muscle appears to contain no cytosolic enzyme but high activities of the membrane-bound form (17, 54).

4.  SR

A membrane-bound CA was detected in preparations of SR vesicles from red as well as white skeletal muscle of the rabbit (17). This finding was confirmed by histochemical results employing the fluorescent CA inhibitor dansylsulfonamide for CA staining (17, 26). Although it has not been possible to visualize SR-CA immunocytochemically at the light microscopic level (157), membrane-bound CA IV was found to be associated with SR by electron microscopy and use of CA IV antibodies (24). This latter finding corresponds with a reaction of SR membranes with anti-CA IV in Western blots (175). Wetzel and Gros (180) have found that nevertheless the inhibitory properties of the CA of SR toward sulfonamides are significantly different from those of the CA of the sarcolemma, which may indicate either that SR-CA is an isoform somewhat different from CA IV or has different properties because of a different membrane environment. In the mammalian heart, immunocytochemical evidence at the electron microscopic level indicates that CA IV is also associated with the SR (156).

5.  Mitochondria

Mitochondrial CA, CA V, is present in high activities in liver and kidney mitochondria (see review, Ref. 60). In skeletal muscle, mitochondrial CA was found only in muscles of the guinea pig but was not detectable in skeletal muscles of the rabbit or the rat or the mouse (Table 6). Carbonic anhydrase V has been detected in immunocytochemical studies in the mitochondria of rat skeletal muscle in addition to those in several other rat <